These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Immunotherapy of mice bearing myeloma and EL4 leukemia]. Kitasato M Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):958-65. PubMed ID: 2447213 [No Abstract] [Full Text] [Related]
25. [Immunotherapy of breast cancer (review of foreign literature)]. Liapis MA Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428 [No Abstract] [Full Text] [Related]
27. Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines. Hanna MG; Peters LC; Hoover HC Prog Clin Biol Res; 1989; 310():51-65. PubMed ID: 2672023 [No Abstract] [Full Text] [Related]
28. Non-specific and specific active immunotherapy in a B16 murine melanoma system. Avent J; Vervaert C; Seigler HF J Surg Oncol; 1979; 12(1):87-96. PubMed ID: 480953 [TBL] [Abstract][Full Text] [Related]
29. [Immunotherapy of malignant diseases. A way towards the goal?]. Riethmüller G MMW Munch Med Wochenschr; 1978 Feb; 120(6):161-2. PubMed ID: 305530 [No Abstract] [Full Text] [Related]
31. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors. Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718 [No Abstract] [Full Text] [Related]
32. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei. Yarkoni E; Rapp HJ Oncology; 1982; 39(5):314-8. PubMed ID: 7099513 [TBL] [Abstract][Full Text] [Related]
33. Immunotherapeutic effect of a polyantigenic vaccine in animal tumor models. Colón JI; Marchand AM; Román Franco AA; Santiago Delpín EA Bol Asoc Med P R; 1981 Apr; 73(4):162-7. PubMed ID: 6946783 [No Abstract] [Full Text] [Related]
34. [Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy]. Saggese V; Zanda G Minerva Pediatr; 1974 Jun; 26(21):1087-93. PubMed ID: 4526571 [No Abstract] [Full Text] [Related]
35. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities. Greager JA; Baldwin RW Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584 [No Abstract] [Full Text] [Related]
37. [Immunomodulating properties of Acnevac vaccine]. Marcinkiewicz J; Bryniarski K; Nowak B; Dzielska D; Payerhin F Med Dosw Mikrobiol; 1991; 43(3-4):167-74. PubMed ID: 1840429 [TBL] [Abstract][Full Text] [Related]
38. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors. Peters LC; Brandhorst JS; Hanna MG Cancer Res; 1979 Apr; 39(4):1353-60. PubMed ID: 217533 [No Abstract] [Full Text] [Related]
39. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide. Fisher B; Gebhardt M; Linta J; Saffer E Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170 [No Abstract] [Full Text] [Related]
40. Introduction: animal models of immunotherapy of cancer. Rapp HJ Natl Cancer Inst Monogr; 1973 Dec; 39():1-2. PubMed ID: 4595318 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]